Mizuho Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price

Lam Research (NASDAQ:LRCX) had its price target upped by Mizuho from $170.00 to $200.00 in a report published on Wednesday, MarketBeat.com reports. The firm currently has an outperform rating on the semiconductor company’s stock.

Other equities research analysts have also issued reports about the stock. Needham & Company LLC increased their target price on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Wall Street Zen lowered Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. JPMorgan Chase & Co. lifted their target price on Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. UBS Group reissued a “buy” rating and set a $175.00 target price (up from $165.00) on shares of Lam Research in a research note on Tuesday, November 25th. Finally, B. Riley upped their price target on Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a report on Monday, October 20th. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $158.54.

Lam Research Trading Down 5.1%

Shares of NASDAQ LRCX opened at $154.98 on Wednesday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $194.66 billion, a PE ratio of 34.14, a PEG ratio of 1.68 and a beta of 1.77. Lam Research has a twelve month low of $56.32 and a twelve month high of $169.69. The stock has a fifty day simple moving average of $153.54 and a 200-day simple moving average of $121.88.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.Lam Research’s revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts forecast that Lam Research will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is presently 22.91%.

Insiders Place Their Bets

In related news, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 102,608 shares of company stock worth $14,916,496 over the last 90 days. Insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

Several hedge funds and other institutional investors have recently bought and sold shares of LRCX. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research during the second quarter worth about $26,000. Stance Capital LLC purchased a new position in Lam Research during the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in Lam Research during the second quarter worth approximately $27,000. Triumph Capital Management acquired a new position in Lam Research during the third quarter worth approximately $27,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in Lam Research in the second quarter valued at approximately $29,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.